The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App 
Professionals >> Visit The Body PROThe Body en Espanol
The Body Covers:
The 40th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy
Metro Toronto Convention Centre, Toronto, Ontario, Canada

September 17-20, 2000

     Cal Cohen, M.D.   Edwin Dejesus, M.D.   Alvan Fisher, M.D.     
    Cal Cohen, M.D. Edwin DeJesus, M.D. Alvan Fisher, M.D.    

The Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), an annual meeting of American Society for Microbiology, is the major international meeting on antimicrobial agents and infectious diseases.

In addition to its scientific symposia, the conference includes special lectures, slide sessions, poster presentations, minilectures, meet-the-experts roundtables, interactive sessions and will this year include an opening session on AIDS. Complementing the invited sessions are an increased number of abstract sessions, which allow for the presentation of new and significant developments in therapy, prevention, pathogenesis, epidemiology, immunology and diagnosis of both established and emerging infectious diseases.

Funding for this conference coverage at The Body is provided, in part, through unrestricted educational grants by Agouron Pharmaceuticals, Inc.; DuPont Pharmaceuticals Company; Glaxo Wellcome Inc.; Merck & Co., Inc.; Ortho Biotech, Inc.; and Roxane Laboratories, Inc.

The Body's Conference Summaries
Day One
September 17
Day Two
September 18
Day Three
September 19
Day Four
September 20

Pharmacoeconomics and Epidemiology of Antibiotic Use

Meet the Experts Session

Drug-Drug Interactions in HIV Infections

Potential Role of Protease Inhibitor-Sparing Regimens in Antiretroviral Therapy

Clinical Trials of Antiretroviral Therapy

New Anti-HIV Agents

Pathogenesis of HIV Disease and other Retrovirus Diseases

Immunology of HIV Infection

Clinical Trials of Antiretroviral Therapy

Adherence to Antiretroviral Therapy

Primary HIV Infection

Symposium: Viral Co-Infection with HIV

New Approaches with Antiretroviral Therapy

Analysis of Genotypes Prior to Antiretroviral Therapy

Antiretroviral Resistance and Resistance Testing

Lipodystrophy and Metabolic Disorders in HIV Therapeutics

Lipodystrophy and Metabolic Complications of HIV

Strategies for Switching Antiretroviral Therapy

Antiretroviral Drug-Drug Interactions and Adverse Effects

Pharmacokinetics and Pharmacodynamics of Antiretroviral Drugs

Symposium: New Challenges in Antiretroviral Therapy and Patient Management of HIV

Changing Epidemiology of HIV Disease

The Impact of HAART on the Outcome of HIV Disease: Challenges for Clinical Trial Design

Novel Aspects of Resistance to Antiretroviral Agents

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.